Poulvac Maternavac IBD-Reo (Canada)

Company: Zoetis

Bursal Disease-Reovirus Vaccine

Standard & Variant, Killed Virus

For Veterinary Use Only

This product has been shown to be effective for the vaccination of healthy primed chickens between 16 and 22 weeks of age against standard and variant infectious bursal disease and malabsorption due to reovirus. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

The vaccine has been shown to be effective in progeny of vaccinates against standard and variant infectious bursal disease and malabsorption due to reovirus.

Directions For Use

Inject 0.5 mL intramuscularly or subcutaneously (in the lower neck region) using aseptic technique. Vaccinate only healthy birds. For primed birds, a single dose between 16 and 22 weeks (approximately 4 weeks prior to lay) is indicated.

Precautions

Store at 2°-8°C. Do not freeze. Warm to 22°-32°C and shake well before using. Use entire contents when first opened. Do not vaccinate within 42 days before slaughter. Contains gentamicin, amphotericin B and formaldehyde as preservatives. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Canada Inc. Veterinary Services, (800) 461-0917.

VLN 190/PCN 12D5.T0

Zoetis Inc., Kalamazoo, MI 49007, USA

January 2024

CPN: 1198437.3